LORI SIKORRA: Open Payments
NPI 1316428345 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 45 payments from 13 companies in 2025. Trend: 2023 $530 · 2024 $739 · 2025 $1,126
Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $255 |
| Alnylam Pharmaceuticals Inc. | 3 | $151 |
| Merck Sharp & Dohme LLC | 5 | $147 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 12 | $129 |
| Novartis Pharmaceuticals Corporation | 4 | $119 |
| Amgen Inc. | 6 | $114 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| BIOTRONIK INC. | 2 | $35 |
| ABIOMED | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
Products named: AMVUTTRA, VERQUVO, WATCHMAN Access System, LifeVest, FARAPULSE, LEQVIO, Repatha, FARXIGA.
Industry payments across CA — which companies pay providers there.
